Morbidity and Mortality in Iranian Children with Juvenile Systemic Lupus erythematosus

Fariba Tavangar-Rad1, Vahid Ziaee2, Mohammad-Hassan Moradinejad3

  • 1Growth and Development Research Center.

Insights

Juvenile systemic lupus erythematosus (JSLE) impacts multiple organs, with poorer prognosis in children. This study found a 10% mortality rate, with liver, cardiac, and pulmonary involvement significantly increasing mortality risk in pediatric SLE patients.

Area of Science:

  • Pediatric Rheumatology
  • Systemic Autoimmune Diseases

Background:

  • Juvenile systemic lupus erythematosus (JSLE) is a significant rheumatologic condition affecting children, often with a poorer prognosis compared to adult-onset lupus.
  • Understanding mortality and morbidity patterns in pediatric SLE is crucial for improving patient outcomes.

Purpose of the Study:

  • To determine the mortality and morbidity rates in children diagnosed with systemic lupus erythematosus (SLE) in Iran.
  • To identify factors associated with increased mortality in pediatric SLE.

Main Methods:

  • A cross-sectional study evaluated 120 children with SLE from a pediatric rheumatology database (2004-2010).
  • Data collected included demographics, age at diagnosis and study, organ involvement, remission status, and mortality.
  • Statistical analysis identified significant differences in organ involvement across age groups and sexes, and associations with remission and mortality.

Main Results:

  • The study included 120 pediatric SLE patients (77% female), with a mean follow-up of 56 months.
  • The overall mortality rate was 10%.
  • Musculoskeletal, oral ulcer, ophthalmic, cardiovascular, and renal involvement showed significant associations with age, sex, or remission status. Cardiac, pulmonary, and liver involvement were significantly associated with increased mortality.

Conclusions:

  • The 1-year and 5-year survival rates were 97% and 89%, respectively.
  • Liver, cardiac, and pulmonary involvement are critical factors associated with higher mortality in juvenile systemic lupus erythematosus.
  • These findings highlight the importance of monitoring and managing these specific organ involvements in pediatric SLE for better survival rates.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.6K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
377
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
391
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
362
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K